William Blair International Ldrs I WILIX

Medalist Rating as of | See William Blair Investment Hub
  • NAV / 1-Day Return 21.13  /  +0.62 %
  • Total Assets 1.2 Bil
  • Adj. Expense Ratio
    0.900%
  • Expense Ratio 0.900%
  • Distribution Fee Level Above Average
  • Share Class Type Institutional
  • Category Foreign Large Growth
  • Investment Style Large Growth
  • Min. Initial Investment 500,000
  • Status Open
  • TTM Yield 0.41%
  • Turnover 50%

USD | NAV as of Oct 04, 2024 | 1-Day Return as of Oct 04, 2024, 10:29 PM GMT+0

Morningstar’s Analysis WILIX

Will WILIX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

William Blair International Ldrs I’s management team is rated Average, but a solid investment process still helps this strategy retain its Morningstar Medalist Rating of Bronze.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The strategy charges fees in line with its similarly distributed peers, priced within the middle quintile.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings WILIX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 25.6
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Novo Nordisk AS Class B

3.90 46.2 Mil
Healthcare

Taiwan Semiconductor Manufacturing Co Ltd

2.77 32.9 Mil
Technology

AstraZeneca PLC

2.59 30.8 Mil
Healthcare

Reliance Industries Ltd

2.47 29.3 Mil
Energy

Hoya Corp

2.42 28.8 Mil
Healthcare

ASML Holding NV

2.33 27.7 Mil
Technology

London Stock Exchange Group PLC

2.31 27.5 Mil
Financial Services

Compass Group PLC

2.29 27.2 Mil
Consumer Cyclical

Icon PLC

2.24 26.6 Mil
Healthcare

MercadoLibre Inc

2.22 26.4 Mil
Consumer Cyclical

Sponsor Center